OTLK earnings: a positive outcome, +5.1%

On February 14, 2024, Outlook Therapeutics, Inc. reached its earnings. The result was a positive outcome, and the stock moved +5.1% in the window around the event. It had already run +12.5% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.